El nuevo suplemento del J. Antimicrob. Chemotherapy trata sobre las infecciones en UCI, con capítulos de especial interés como el uso de antibióticos, o una revisión sobre la Procalcitonina, tratando la importancia en el diagnóstico de un proceso infeccioso, utilidad como marcador para suspender el tratamiento antibiótico, y el valor pronóstico en la sepsis.
Infection in the critically ill--questions we should be asking [1]
John R. Prowle, Sarah Heenen, and Mervyn Singer
J. Antimicrob. Chemother. 2011 66: ii3-ii10.
Surviving the first hours in sepsis: getting the basics right (an intensivist's perspective) [2]
Ron Daniels
J. Antimicrob. Chemother. 2011 66: ii11-ii23.
Antibiotic dosing in critical illness [3]
Cathrine McKenzie
J. Antimicrob. Chemother. 2011 66: ii25-ii31.
Diagnostic and prognostic biomarkers of sepsis in critical care [4]
Savitri Kibe, Kate Adams, and Gavin Barlow
J. Antimicrob. Chemother. 2011 66: ii33-ii40.
Jonathan D. Edgeworth
J. Antimicrob. Chemother. 2011 66: ii41-ii47.
Enlaces:
[1] http://jac.oxfordjournals.org/content/66/suppl_2/ii3.full.pdf+html
[2] http://jac.oxfordjournals.org/content/66/suppl_2/ii11.full.pdf+html
[3] http://jac.oxfordjournals.org/content/66/suppl_2/ii25.full.pdf+html
[4] http://jac.oxfordjournals.org/content/66/suppl_2/ii33.full.pdf+html
[5] http://jac.oxfordjournals.org/content/66/suppl_2/ii41.full.pdf+html
[6] http://privada.semicyuc.org/temas/publicaciones